VivoSim Labs, Inc. ( VIVS) - Stock Earnings
VIVS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| June 17, 2026 BeforeMarket | — / — | — | — / — | — |
VIVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -2.8 million USD | 37000 USD |
| 2025Q3 | -2.5 million USD | 28000 USD |
| 2025Q4 | -2.7 million USD | 26000 USD |
VIVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.3 million USD | 370000 USD |
| 2024 | -14.7 million USD | 109000 USD |
| 2025 | -2.5 million USD | 144000 USD |
| 2026 Est. | — | — |
VIVS
Price: $1.10
52 week price:
Earnings Per Share: 1.76 USD
P/E Ratio: 0.63
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 million